CIM vs EXPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Chimera Investment Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. While the stock appears undervalued based on a Price/Book of 0.44 and a Graham Number of $34.55, these metrics are likely 'value traps' given the high Debt/Equity ratio of 5.08 and a consistent track record of earnings misses. The technical trend is completely bearish (0/100), and the high dividend yield (13.26%) is precarious given the deteriorating health scores. Overall, the valuation discount is a reflection of systemic risk rather than an opportunity.
EXPI shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
CIM vs EXPI: Head-to-Head Comparison
This page compares Chimera Investment Corporation (CIM) and eXp World Holdings, Inc. (EXPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.